Tirzepatide cuts fat mass 35% while sparing skeletal muscle

The wire

1. 01Reported analysis found tirzepatide reduced fat mass by about 35% while skeletal muscle was preserved.
2. 02Muscle loss is the standing clinical worry with incretin-driven weight loss, so body-composition data bear directly on how prescribers counsel and monitor patients.
3. 03Details on sample size, imaging method, duration and funding determine how much weight to give the result; readers should check the underlying publication.

From the source

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle